Maes M: Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995, 19: 11-38.
Maes M, Berk M, Goehler L, Song C, Anderson G, Galecki P, Leonard B: Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med. 2012, 10: 66.
Moylan S, Maes M, Wray NR, Berk M: The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry. 2012, 18: 595-606.
Leonard B, Maes M: Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev. 2012, 36: 764-785.
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL: A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010, 67: 446-457.
Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, Schneider HG, Leonard BE, Berk M: Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry. 2010, 197: 372-377.
Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T: Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001, 58: 445-452.
Udina M, Castellvi P, Moreno-Espana J, Navines R, Valdes M, Forns X, Langohr K, Sola R, Vieta E, Martin-Santos R: Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry. 2012, 73: 1128-1138.
Connor TJ, Leonard BE: Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci. 1998, 62: 583-606.
Xia Z, DePierre JW, Nassberger L: Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology. 1996, 34: 27-37.
Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, De Jongh R, Bosmans E, Scharpe S: Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology. 1999, 20: 370-379.
Galecki P, Galecka E, Maes M, Chamielec M, Orzechowska A, Bobinska K, Lewinski A, Szemraj J: The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder. J Affect Disord. 2012, 138: 360-366.
Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, Craig IW, Anacker C, Zunsztain PA, McGuffin P, Pariante CM: Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline ‘predictors’ and longitudinal ‘targets’. Neuropsychopharmacology. 2013, 38: 377-385.
Maes M, Fisar Z, Medina M, Scapagnini G, Nowak G, Berk M: New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology. 2012, 20: 127-150.
Hannestad J, DellaGioia N, Bloch M: The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 2011, 36: 2452-2459.
Eller T, Vasar V, Shlik J, Maron E: Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2008, 32: 445-450.
Maes M, Ombelet W, De Jongh R, Kenis G, Bosmans E: The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J Affect Disord. 2001, 63: 85-92.
Moller M, Du Preez JL, Viljoen F, Berk M, Emsley R, Harvey BH: Social isolation rearing induces immunological, neurochemical, mitochondrial and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine. Brain Behav Immun. 2012, 18: 156-167.
Persoons JH, Schornagel K, Breve J, Berkenbosch F, Kraal G: Acute stress affects cytokines and nitric oxide production by alveolar macrophages differently. Am J Respir Crit Care Med. 1995, 152: 619-624.
Nguyen KT, Deak T, Owens SM, Kohno T, Fleshner M, Watkins LR, Maier SF: Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci. 1998, 18: 2239-2246.
Maier SF, Watkins LR: Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res. 1995, 695: 279-282.
Kubera M, Symbirtsev A, Basta-Kaim A, Borycz J, Roman A, Papp M, Claesson M: Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Pol J Pharmacol. 1996, 48: 503-506.
Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS: Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology. 1993, 133: 2523-2530.
Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M: In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 744-759.
Dobbin JP, Harth M, McCain GA, Martin RA, Cousin K: Cytokine production and lymphocyte transformation during stress. Brain Behav Immun. 1991, 5: 339-348.
Mittwoch-Jaffe T, Shalit F, Srendi B, Yehuda S: Modification of cytokine secretion following mild emotional stimuli. Neuroreport. 1995, 6: 789-792.
Deinzer R, Forster P, Fuck L, Herforth A, Stiller-Winkler R, Idel H: Increase of crevicular interleukin 1beta under academic stress at experimental gingivitis sites and at sites of perfect oral hygiene. J Clin Periodontol. 1999, 26: 1-8.
Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, Bosmans E, De Meester I, Benoy I, Neels H, Demedts P, Janca A, Scharpé S, Smith RS: The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine. 1998, 10: 313-318.
Maes M, Song C, Lin A, DeJong R, van Gastel A, Kenis G, Bosmans E, DeMeester I, Neels H, Janca A, Scharpe S, Smith RS: Immune and Clinical Correlates of Psychological Stress-Induced Production of Interferon-γ and IL-10 in Humans. Edited by: Plotnikoff NP, Faith RE, Murgo AJ, Good RA. 1998, Boca Raton, FL: Raven Press, chapter 3
Song C, Kenis G, van Gastel A, Bosmans E, Lin A, de Jong R, Neels H, Scharpe S, Janca A, Yasukawa K, Maes M: Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes. Psychiatry Res. 1999, 85: 293-303.
Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J: Depression’s multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett. 2011, 32: 7-24.
Danese A, Pariante CM, Caspi A, Taylor A, Poulton R: Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA. 2007, 104: 1319-1324.
Kiecolt-Glaser J, Gouin J, Weng N, Malarkey W, Beversdorf D, Glasert R: Childhood adversity heightens the impact of later-life caregiving stress on telomere length and inflammation. Psychosom Med. 2011, 73: 16-22.
Miller GE, Cole SW: Clustering of depression and inflammation in adolescents previously exposed to childhood adversity. Biol Psychiatry. 2012, 72: 34-40.
Korkeila J, Vahtera J, Korkeila K, Kivimäki M, Sumanen M, Koskenvuo K, Koskenvuo M: Childhood adversities as predictors of incident coronary heart disease and cerebrovascular disease. Heart. 2010, 96: 298-303.
McIntyre RS, Soczynska JK, Liauw SS, Woldeyohannes HO, Brietzke E, Nathanson J, Alsuwaidan M, Muzina DJ, Taylor VH, Cha DS, Kennedy SH: The association between childhood adversity and components of metabolic syndrome in adults with mood disorders: results from the international mood disorders collaborative project. Int J Psychiatry Med. 2012, 43: 165-177.
Wadee AA, Kuschke RH, Kometz S, Berk M: Personality factors, stress and immunity. Stress Heal. 2001, 17: 25-40.
Slavich GM, O’Donovan A, Epel ES, Kemeny ME: Black sheep get the blues: a psychobiological model of social rejection and depression. Neurosci Biobehav Rev. 2010, 35: 39-45.
Emeny R, Lacruz M-E, Baumert J, Zierer A, von Eisenhart Rothe A, Autenrieth C, Herder C, Koenig W, Thorand B, Ladwig K-H: Job strain associated CRP is mediated by leisure time physical activity: results from the MONICA/KORA study. Brain Behav Immun. 2012, 26: 1077-1084.
LaMontagne AD, Keegel T, Vallance D, Ostry A, Wolfe R: Job strain - attributable depression in a sample of working Australians: assessing the contribution to health inequalities. BMC Publ Health. 2008, 8: 181.
Drewnowski A, Popkin BM: The nutrition transition: new trends in the global diet. Nutr Rev. 1997, 55: 31-43.
Jacka FN, Pasco JA, Mykletun A, Williams LJ, Hodge AM, O’Reilly SL, Nicholson GC, Kotowicz MA, Berk M: Association of Western and traditional diets with depression and anxiety in women. Am J Psychiatry. 2010, 167: 305-311.
Jacka FN, Mykletun A, Berk M, Bjelland I, Tell GS: The association between habitual diet quality and the common mental disorders in community-dwelling adults: the Hordaland Health Study. Psychosom Med. 2011, 73: 483-490.
Nanri A, Kimura Y, Matsushita Y, Ohta M, Sato M, Mishima N, Sasaki S, Mizoue T: Dietary patterns and depressive symptoms among Japanese men and women. Eur J Clin Nutr. 2010, 64: 832-839.
Kuczmarski MF, Cremer Sees A, Hotchkiss L, Cotugna N, Evans MK, Zonderman AB: Higher healthy eating index-2005 scores associated with reduced symptoms of depression in an urban population: findings from the Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS) study. J Am Diet Assoc. 2010, 110: 383-389.
Akbaraly TN, Brunner EJ, Ferrie JE, Marmot MG, Kivimaki M, Singh-Manoux A: Dietary pattern and depressive symptoms in middle age. Br J Psychiatry. 2009, 195: 408-413.
Sanchez-Villegas A, Delgado-Rodriguez M, Alonso A, Schlatter J, Lahortiga F, Serra Majem L, Martinez-Gonzalez MA: Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Arch Gen Psychiatry. 2009, 66: 1090-1098.
Sanchez-Villegas A, Toledo E, de Irala J, Ruiz-Canela M, Pla-Vidal J, Martinez-Gonzalez MA: Fast-food and commercial baked goods consumption and the risk of depression. Public Health Nutr. 2012, 15: 424-432.
Kohlboeck G, Sausenthaler S, Standl M, Koletzko S, Bauer CP, von Berg A, Berdel D, Kramer U, Schaaf B, Lehmann I, Herbarth O, Herbarth JH, GINI-plus and LISA-plus Study: Food intake, diet quality and behavioral problems in children: results from the GINI-plus/LISA-plus studies. Ann Nutr Metab. 2012, 60: 247-256.
Jacka FN, Kremer PJ, Berk M, de Silva-Sanigorski AM, Moodie M, Leslie ER, Pasco JA, Swinburn BA: A prospective study of diet quality and mental health in adolescents. PLoS One. 2011, 6: e24805.
Jacka FN, Kremer PJ, Leslie ER, Berk M, Patton GC, Toumbourou JW, Williams JW: Associations between diet quality and depressed mood in adolescents: results from the Australian Healthy Neighbourhoods Study. Aust N Z J Psychiatry. 2010, 44: 435-442.
Weng TT, Hao JH, Qian QW, Cao H, Fu JL, Sun Y, Huang L, Tao FB: Is there any relationship between dietary patterns and depression and anxiety in Chinese adolescents?. Public Health Nutr. 2012, 15: 673-682.
Niu K, Guo H, Kakizaki M, Cui Y, Ohmori-Matsuda K, Guan L, Hozawa A, Kuriyama S, Tsuboya T, Ohrui T, Furukawa K, Arai H, Tsuji I, Nagatomi R: A tomato-rich diet is related to depressive symptoms among an elderly population aged 70 years and over: a population-based, cross-sectional analysis. J Affect Disord. 2013, 144: 165-170.
Johnson LA, Phillips JA, Mauer C, Edwards M, Balldin VH, Hall JR, Barber R, Conger TL, O’Bryant SE: The impact of GPX1 on the association of groundwater selenium and depression: a project FRONTIER study. BMC Psychiatry. 2013, 13: 7.
Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY: Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999, 85: 275-291.
Lopez-Garcia E, Schulze MB, Fung TT, Meigs JB, Rifai N, Manson JE, Hu FB: Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2004, 80: 1029-1035.
Fung TT, Rimm EB, Spiegelman D, Rifai N, Tofler GH, Willett WC, Hu FB: Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr. 2001, 73: 61-67.
Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C: Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol. 2004, 44: 152-158.
Volman JJ, Ramakers JD, Plat J: Dietary modulation of immune function by beta-glucans. Physiol Behav. 2008, 94: 276-284.
Tachon S, Zhou J, Keenan M, Martin R, Marco ML: The intestinal microbiota in aged mice is modulated by dietary resistant starch and correlated with improvements in host responses. FEMS Microbiol Ecol. 2013, 83: 299-309.
Parikh S, Pollock NK, Bhagatwala J, Guo DH, Gutin B, Zhu H, Dong Y: Adolescent fiber consumption is associated with visceral fat and inflammatory markers. J Clin Endocrinol Metab. 2012, 97: E1451-1457.
Jacobs DR, Andersen LF, Blomhoff R: Whole-grain consumption is associated with a reduced risk of noncardiovascular, noncancer death attributed to inflammatory diseases in the Iowa Women’s Health Study. Am J Clin Nutr. 2007, 85: 1606-1614.
Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O: Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord. 2001, 64: 43-51.
Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM: Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002, 75: 492-498.
Levitan EB, Cook NR, Stampfer MJ, Ridker PM, Rexrode KM, Buring JE, Manson JE, Liu S: Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein. Metabolism. 2008, 57: 437-443.
Rangel-Huerta OD, Aguilera CM, Mesa MD, Gil A: Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br J Nutr. 2012, 107: S159-170.
Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002, 56: 365-379.
Clarke R, Shipley M, Armitage J, Collins R, Harris W: Plasma phospholipid fatty acids and CHD in older men: Whitehall study of London civil servants. Br J Nutr. 2009, 102: 279-284.
Iwata NG, Pham M, Rizzo NO, Cheng AM, Maloney E, Kim F: Trans fatty acids induce vascular inflammation and reduce vascular nitric oxide production in endothelial cells. PLoS One. 2011, 6: e29600.
King DE, Mainous AG, Geesey ME, Woolson RF: Dietary magnesium and C-reactive protein levels. J Am Coll Nutr. 2005, 24: 166-171.
Watzl B, Kulling SE, Moseneder J, Barth SW, Bub A: A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. Am J Clin Nutr. 2005, 82: 1052-1058.
Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R, Emam A, Parker TL, Vidgen E, Lapsley KG, Trautwein EA, Josse RG, Leiter LA, Connelly PW: Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA. 2003, 290: 502-510.
Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D’Armiento M, D’Andrea F, Giugliano D: Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004, 292: 1440-1446.
Sorensen LB, Raben A, Stender S, Astrup A: Effect of sucrose on inflammatory markers in overweight humans. Am J Clin Nutr. 2005, 82: 421-427.
Pistell PJ, Morrison CD, Gupta S, Knight AG, Keller JN, Ingram DK, Bruce-Keller AJ: Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol. 2012, 219: 25-32.
Bilbo SD, Tsang V: Enduring consequences of maternal obesity for brain inflammation and behavior of offspring. FASEB J. 2012, 24: 2104-2115.
Moreira AP, Texeira TF, Ferreira AB, Peluzio Mdo C, Alfenas Rde C: Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr. 2012, 108: 801-809.
Delzenne NM, Neyrinck AM, Cani PD: Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact. 2012, 10: S10.
Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR: Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009, 461: 1282-1286.
Conn VS: Depressive symptom outcomes of physical activity interventions: meta-analysis findings. Ann Behav Med. 2010, 39: 128-138.
Greist JH, Klein MH, Eischens RR, Faris J, Gurman AS, Morgan WP: Running as treatment for depression. Compr Psychiatry. 1979, 20: 41-54.
Pasco JA, Williams LJ, Jacka FN, Henry MJ, Coulson CE, Brennan SL, Leslie E, Nicholson GC, Kotowicz MA, Berk M: Habitual physical activity and the risk for depressive and anxiety disorders among older men and women. Int Psychogeriatr. 2011, 23: 292-298.
Strawbridge WJ, Deleger S, Roberts RE, Kaplan GA: Physical activity reduces the risk of subsequent depression for older adults. Am J Epidemiol. 2002, 156: 328-334.
Brown WJ, Ford JH, Burton NW, Marshall AL, Dobson AJ: Prospective study of physical activity and depressive symptoms in middle-aged women. Am J Prev Med. 2005, 29: 265-272.
Jacka FN, Pasco JA, Williams LJ, Leslie ER, Dodd S, Nicholson GC, Kotowicz MA, Berk M: Lower levels of physical activity in childhood associated with adult depression. J Sci Med Sport. 2010, 14: 222-226.
Farmer ME, Locke BZ, Moscicki EK, Dannenberg AL, Larson DB, Radloff LS: Physical activity and depressive symptoms: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 1988, 128: 1340-1351.
Wiles NJ, Haase AM, Gallacher J, Lawlor DA, Lewis G: Physical activity and common mental disorder: results from the Caerphilly study. Am J Epidemiol. 2007, 165: 946-954.
Sanchez-Villegas A, Ara I, Guillen-Grima F, Bes-Rastrollo M, Varo-Cenarruzabeitia JJ, Martinez-Gonzalez MA: Physical activity, sedentary index, and mental disorders in the SUN cohort study. Med Sci Sports Exerc. 2008, 40: 827-834.
Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, Minson CT, Nigg CR, Salem GJ, Skinner JS: American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc. 2009, 41: 1510-1530.
Scott D, Blizzard L, Fell J, Jones G: Ambulatory activity, body composition, and lower-limb muscle strength in older adults. Med Sci Sports Exerc. 2009, 41: 383-389.
Kim T, Park M, Lim K, Choi H, Yang S, Yoo H, Kang H, Song W, Choi H, Baik S, Choi DS, Choi KM: Relationships between sarcopenic obesity and insulin resistance, inflammation, and Vitamin D status: the Korean Sarcopenic Obesity Study (KSOS). Clin Endocrinol (Oxf). 2012
Canon ME, Crimmins EM: Sex differences in the association between muscle quality, inflammatory markers, and cognitive decline. J Nutr Health Aging. 2011, 15: 695-698.
Sachdev S, Davies KJ: Production, detection, and adaptive responses to free radicals in exercise. Free Radic Biol Med. 2008, 44: 215-223.
Kramer HF, Goodyear LJ: Exercise, MAPK, and NF-kappaB signaling in skeletal muscle. J Appl Physiol. 2007, 103: 388-395.
Febbraio MA, Pedersen BK: Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J. 2002, 16: 1335-1347.
Pedersen BK, Fischer CP: Physiological roles of muscle-derived interleukin-6 in response to exercise. Curr Opin Clin Nutr Metab Care. 2007, 10: 265-271.
Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK: Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol. 1999, 515: 287-291.
Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A, Simon P: Position statement. Part one: Immune function and exercise. Exerc Immunol Rev. 2011, 17: 6-63.
Teixeira de Lemos E, Pinto R, Oliveira J, Garrido P, Sereno J, Mascarenhas-Melo F, Pascoa-Pinheiro J, Teixeira F, Reis F: Differential effects of acute (extenuating) and chronic (training) exercise on inflammation and oxidative stress status in an animal model of type 2 diabetes mellitus. Mediators Inflamm. 2011, 2011: 253061.
Bobbert T, Mai K, Brechtel L, Schulte HM, Weger B, Pfeiffer AF, Spranger J, Diederich S: Leptin and endocrine parameters in marathon runners. Int J Sports Med. 2012, 33: 244-248.
Pasco JA, Jacka FN, Williams LJ, Henry MJ, Nicholson GC, Kotowicz MA, Berk M: Leptin in depressed women: cross-sectional and longitudinal data from an epidemiologic study. J Affect Disord. 2008, 107: 221-225.
Stuart MJ, Baune BT: Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci Biobehav Rev. 2012, 36: 658-676.
Allison MA, Jensky NE, Marshall SJ, Bertoni AG, Cushman M: Sedentary behavior and adiposity-associated inflammation: the Multi-Ethnic Study of Atherosclerosis. Am J Prev Med. 2012, 42: 8-13.
Koster A, Caserotti P, Patel KV, Matthews CE, Berrigan D, Van Domelen DR, Brychta RJ, Chen KY, Harris TB: Association of sedentary time with mortality independent of moderate to vigorous physical activity. PLoS One. 2012, 7: e37696.
Vancampfort D, Correll CU, Probst M, Sienaert P, Wyckaert S, De Herdt A, Knapen J, De Wachter D, De Hert M: A review of physical activity correlates in patients with bipolar disorder. J Affect Disord. 2013, 105: 285-291.
Hamilton MT, Hamilton DG, Zderic TW: Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes. 2007, 56: 2655-2667.
Racette SB, Deusinger SS, Deusinger RH: Obesity: overview of prevalence, etiology, and treatment. Phys Ther. 2003, 83: 276-288.
Pasco JA, Nicholson GC, Brennan SL, Kotowicz MA: Prevalence of obesity and the relationship between the body mass index and body fat: cross-sectional, population-based data. PLoS One. 2012, 7: e29580.
Kopelman PG: Obesity as a medical problem. Nature. 2000, 404: 635-643.
de Wit L, Luppino F, van Straten A, Penninx B, Zitman F, Cuijpers P: Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res. 2010, 178: 230-235.
Williams LJ, Pasco JA, Henry MJ, Jacka FN, Dodd S, Nicholson GC, Kotowicz MA, Berk M: Lifetime psychiatric disorders and body composition: a population-based study. J Affect Disord. 2009, 118: 173-179.
Faith MS, Butryn M, Wadden TA, Fabricatore A, Nguyen AM, Heymsfield SB: Evidence for prospective associations among depression and obesity in population-based studies. Obes Rev. 2011, 12: e438-453.
Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, Zitman FG: Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010, 67: 220-229.
de Heredia FP, Gomez-Martinez S, Marcos A: Obesity, inflammation and the immune system. Proc Nutr Soc. 2012, 71: 332-338.
Arvidsson E, Viguerie N, Andersson I, Verdich C, Langin D, Arner P: Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes. 2004, 53: 1966-1971.
Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C: The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis. 2005, 183: 308-315.
Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA: Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun. 2003, 17: 276-285.
Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH: Smoking and mental illness: a population-based prevalence study. JAMA. 2000, 284: 2606-2610.
Lawrence D, Mitrou F, Zubrick SR: Smoking and mental illness: results from population surveys in Australia and the United States. BMC Publ Health. 2009, 9: 285.
Pasco JA, Williams LJ, Jacka FN, Ng F, Henry MJ, Nicholson GC, Kotowicz MA, Berk M: Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry. 2008, 193: 322-326.
Boden JM, Fergusson DM, Horwood LJ: Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br J Psychiatry. 2010, 196: 440-446.
Chaiton MO, Cohen JE, O’Loughlin J, Rehm J: A systematic review of longitudinal studies on the association between depression and smoking in adolescents. BMC Publ Health. 2009, 9: 356.
Lyons M, Hitsman B, Xian H, Panizzon MS, Jerskey BA, Santangelo S, Grant MD, Rende R, Eisen S, Eaves L, Tsuang MT: A twin study of smoking, nicotine dependence, and major depression in men. Nicotine Tob Res. 2008, 10: 97-108.
Stedman RL: The chemical composition of tobacco and tobacco smoke. Chem Rev. 1968, 68: 153-207.
Arunachalam G, Sundar IK, Hwang JW, Yao H, Rahman I: Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD. J Inflamm (Lond). 2010, 7: 34.
Virdis A, Giannarelli C, Neves MF, Taddei S, Ghiadoni L: Cigarette smoking and hypertension. Curr Pharm Des. 2010, 16: 2518-2525.
Tamimi A, Serdarevic D, Hanania NA: The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir Med. 2012, 106: 319-328.
Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF: Systemic effects of smoking. Chest. 2007, 131: 1557-1566.
Nunes SO, Vargas HO, Brum J, Prado E, Vargas MM, de Castro MR, Dodd S, Berk M: A comparison of inflammatory markers in depressed and nondepressed smokers. Nicotine Tob Res. 2012, 14: 540-546.
Tuon T, Valvassori SS, Lopes-Borges J, Fries GR, Silva LA, Kapczinski F, Quevedo J, Pinho RA: Effects of moderate exercise on cigarette smoke exposure-induced hippocampal oxidative stress values and neurological behaviors in mice. Neurosci Lett. 2010, 475: 16-19.
Anbarasi K, Vani G, Balakrishna K, Devi CS: Effect of bacoside A on membrane-bound ATPases in the brain of rats exposed to cigarette smoke. J Biochem Mol Toxicol. 2005, 19: 59-65.
Thome GR, Spanevello RM, Mazzanti A, Fiorenza AM, Duarte MM, da Luz SC, Pereira ME, Morsch VM, Schetinger MR, Mazzanti CM: Vitamin E decreased the activity of acetylcholinesterase and level of lipid peroxidation in brain of rats exposed to aged and diluted sidestream smoke. Nicotine Tob Res. 2011, 13: 1210-1219.
Stangherlin EC, Luchese C, Ardais AP, Nogueira CW: Passive smoke exposure induces oxidative damage in brains of rat pups: protective role of diphenyl diselenide. Inhal Toxicol. 2009, 21: 868-874.
Luchese C, Pinton S, Nogueira CW: Brain and lungs of rats are differently affected by cigarette smoke exposure: antioxidant effect of an organoselenium compound. Pharmacol Res. 2009, 59: 194-201.
Anbarasi K, Vani G, Balakrishna K, Devi CS: Effect of bacoside A on brain antioxidant status in cigarette smoke exposed rats. Life Sci. 2006, 78: 1378-1384.
Hilbert J, Mohsenin V: Adaptation of lung antioxidants to cigarette smoking in humans. Chest. 1996, 110: 916-920.
Baskaran S, Lakshmi S, Prasad PR: Effect of cigarette smoke on lipid peroxidation and antioxidant enzymes in albino rat. Indian J Exp Biol. 1999, 37: 1196-1200.
Maes M, Kubera M, Leunis JC: The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. 2008, 29: 117-124.
Maes M, Kubera M, Leunis JC, Berk M, Geffard M, Bosmans E: In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr Scand. 2013, 127: 344-354.
Maes M, Kubera M, Leunis JC, Berk M: Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J Affect Disord. 2012, 141: 55-62.
Wiest R: Bacterial translocation. Bioscience Microflora. 2005, 24: 61-90.
Todar K: Todar’s online textbook of bacteriology. 2012, [http://textbookofbacteriology.net/]
Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB: Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Invest. 1995, 95: 1669-1675.
Lin WN, Lin CC, Cheng HY, Yang CM: Regulation of cyclooxygenase-2 and cytosolic phospholipase A2 gene expression by lipopolysaccharide through the RNA-binding protein HuR: involvement of NADPH oxidase, reactive oxygen species and mitogen-activated protein kinases. Br J Pharmacol. 2011, 163: 1691-1706.
Check J, Byrd CL, Menio J, Rippe RA, Hines IN, Wheeler MD: Src kinase participates in LPS-induced activation of NADPH oxidase. Mol Immunol. 2010, 47: 756-762.
Pai K, Sodhi A: Effect of cisplatin, rIFN-Y, LPS and MDP on release of H2O2, O2- and lysozyme from human monocytes in vitro. Indian J Exp Biol. 1991, 29: 910-915.
Takada K, Ohno N, Yadomae T: Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo. Infect Immun. 1994, 62: 1171-1175.
Berg RD, Garlington AW: Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun. 1979, 23: 403-411.
Wiest R, Garcia-Tsao G: Bacterial translocation (BT) in cirrhosis. Hepatology. 2005, 41: 422-433.
Clark E, Hoare C, Tanianis-Hughes J, Carlson GL, Warhurst G: Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology. 2005, 128: 1258-1267.
Chavez AM, Menconi MJ, Hodin RA, Fink MP: Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med. 1999, 27: 2246-2251.
Yang R, Han X, Uchiyama T, Watkins SK, Yaguchi A, Delude RL, Fink MP: IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol. 2003, 285: G621-629.
Al-Sadi RM, Ma TY: IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol. 2007, 178: 4641-4649.
Ye D, Ma I, Ma TY: Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol. 2006, 290: G496-504.
Maes M, Mihaylova I, Kubera M, Leunis JC, Geffard M: IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology. J Affect Disord. 2011, 135: 414-418.
Garate I, Garcia-Bueno B, Madrigal JL, Caso JR, Alou L, Gomez-Lus ML, Mico JA, Leza JC: Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway. Biol Psychiatry. 2013, 73: 32-43.
Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, van Cauwenberge P, Williams HC: Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol. 2004, 113: 832-836.
Jarvis D, Burney P: ABC of allergies. The epidemiology of allergic disease. BMJ. 1998, 316: 607-610.
Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, Williams H: Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006, 368: 733-743.
Hashiro M, Okumura M: Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity. J Dermatol Sci. 1997, 14: 63-67.
Cuffel B, Wamboldt M, Borish L, Kennedy S, Crystal-Peters J: Economic consequences of comorbid depression, anxiety, and allergic rhinitis. Psychosomatics. 1999, 40: 491-496.
Afari N, Schmaling K, Barnhart S, Buchwald D: Psychiatric comorbidity and functional status in adult patients with asthma. J Clin Psychol Med Settings. 2001, 8: 245-252.
Mizara A, Papadopoulos L, McBride SR: Core beliefs and psychological distress in patients with psoriasis and atopic eczema attending secondary care: the role of schemas in chronic skin disease. Br J Dermatol. 2012, 166: 986-993.
Hurwitz EL, Morgenstern H: Cross-sectional associations of asthma, hay fever, and other allergies with major depression and low-back pain among adults aged 20–39 years in the United States. Am J Epidemiol. 1999, 150: 1107-1116.
Timonen M, Jokelainen J, Hakko H, Silvennoinen-Kassinen S, Meyer-Rochow VB, Herva A, Rasanen P: Atopy and depression: results from the Northern Finland 1966 Birth Cohort Study. Mol Psychiatry. 2003, 8: 738-744.
Klokk M, Gotestam KG, Mykletun A: Factors accounting for the association between anxiety and depression, and eczema: the Hordaland health study (HUSK). BMC Dermatol. 2010, 10: 3.
Yang YW, Tseng KC, Chen YH, Yang JY: Associations among eczema, asthma, serum immunoglobulin E and depression in adults: a population-based study. Allergy. 2010, 65: 801-802.
Gunn JM, Ayton DR, Densley K, Pallant JF, Chondros P, Herrman HE, Dowrick CF: The association between chronic illness, multimorbidity and depressive symptoms in an Australian primary care cohort. Soc Psychiatry Psychiatr Epidemiol. 2012, 47: 175-184.
Prussin C, Metcalfe DD: 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2003, 111: S486-494.
Metcalfe DD, Baram D, Mekori YA: Mast cells. Physiol Rev. 1997, 77: 1033-1079.
Highfield J: Diagnosis and classification of periodontal disease. Aust Dent J. 2009, 54: S11-26.
Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ, CDC Periodontal Disease Surveillance workgroup: James Beck (University of North Carolina, Chapel Hill, USA), Gordon Douglass (Past President, American Academy of Periodontology), Roy Page (University of Washington): Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012, 91: 914-920.
Dumitrescu AL, Kawamura M: Involvement of psychosocial factors in the association of obesity with periodontitis. J Oral Sci. 2010, 52: 115-124.
Monteiro da Silva AM, Oakley DA, Newman HN, Nohl FS, Lloyd HM: Psychosocial factors and adult onset rapidly progressive periodontitis. J Clin Periodontol. 1996, 23: 789-794.
Peruzzo DC, Benatti BB, Ambrosano GM, Nogueira-Filho GR, Sallum EA, Casati MZ, Nociti FH: A systematic review of stress and psychological factors as possible risk factors for periodontal disease. J Periodontol. 2007, 78: 1491-1504.
Adeniyi AA, Ola BA, Edeh CE, Ogunbanjo BO, Adewuya AO: Dental status of patients with mental disorders in a Nigerian teaching hospital: a preliminary survey. Spec Care Dentist. 2011, 31: 134-137.
Okoro CA, Strine TW, Eke PI, Dhingra SS, Balluz LS: The association between depression and anxiety and use of oral health services and tooth loss. Community Dent Oral Epidemiol. 2012, 40: 134-144.
Mendes DC, Silva TF, de Barros LO, de Oliveira MV, Vieira LT, Haikal DS, Guimaraes AL, De Paula AM: Analysis of the normative conditions of oral health, depression and serotonin-transporter-linked promoter region polymorphisms in an elderly population. Geriatr Gerontol Int. 2013, 13: 98-106.
Socransky SS, Haffajee AD: Periodontal microbial ecology. Periodontol. 2005, 38: 135-187.
Page RC, Schroeder HE: Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest. 1976, 34: 235-249.
Amar S, Gokce N, Morgan S, Loukideli M, Van Dyke TE, Vita JA: Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol. 2003, 23: 1245-1249.
Kinane DF, Lowe GD: How periodontal disease may contribute to cardiovascular disease. Periodontol. 2000, 23: 121-126.
Saremi A, Nelson RG, Tulloch-Reid M, Hanson RL, Sievers ML, Taylor GW, Shlossman M, Bennett PH, Genco R, Knowler WC: Periodontal disease and mortality in type 2 diabetes. Diabetes Care. 2005, 28: 27-32.
Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand M: Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med. 2008, 23: 2079-2086.
Hasturk H, Kantarci A, Van Dyke TE: Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol. 2012, 3: 118.
Ara T, Kurata K, Hirai K, Uchihashi T, Uematsu T, Imamura Y, Furusawa K, Kurihara S, Wang PL: Human gingival fibroblasts are critical in sustaining inflammation in periodontal disease. J Periodontal Res. 2009, 44: 21-27.
Van Dyke TE: The management of inflammation in periodontal disease. J Periodontol. 2008, 79: 1601-1608.
Van Dyke TE: Resolution of inflammation-unraveling mechanistic links between periodontitis and cardiovascular disease. J Dent. 2009, 37: S582-583.
Kronfol Z, Remick DG: Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000, 157: 683-694.
Kamer AR, Dasanayake AP, Craig RG, Glodzik-Sobanska L, Bry M, de Leon MJ: Alzheimer’s disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J Alzheimers Dis. 2008, 13: 437-449.
Savage VM, West GB: A quantitative, theoretical framework for understanding mammalian sleep. Proc Natl Acad Sci USA. 2007, 104: 1051-1056.
Kripke DF, Garfinkel L, Wingard D, Klauber MR, Marler MR: Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002, 59: 137-138.
Zisapel N: Sleep and sleep disturbances: biological basis and clinical implications. Cell Mol Life Sci. 2007, 64: 1174-1186.
Fanzen P, Buysse D: Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci. 2008, 10: 473-481.
Bower B, Bylsma LM, Morris BH, Rottenberg J: Poor reported sleep quality predicts low positive affect in daily life among healthy and mood-disordered persons. J Sleep Res. 2010, 19: 323-332.
Turek F: Insomnia and depression: if it looks and walks like a duck. Sleep Res Online. 2005, 28: 1457-1464.
Peterson MJ, Benca RM: Sleep in mood disorders. Psychiatr Clin North Am. 2006, 29: 1009-1032. Abstract ix
Kaneita Y, Ohida T, Uchiyama M, Takemura S, Kawahara K, Yokoyama E, Miyake T, Harano S, Suzuki K, Yagi Y, Kaneko A, Tsutsui T, Akashiba T: Excessive daytime sleepiness among the Japanese general population. J Epidemiol. 2005, 15: 1-8.
Riemann D, Voderholzer U: Primary insomnia: a risk factor to develop depression?. J Affect Disord. 2003, 76: 255-259.
Pigeon WR, Hegel M, Unutzer J, Fan MY, Sateia MJ, Lyness JM, Phillips C, Perlis ML: Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort?. Sleep. 2008, 31: 481-488.
McClung CA: Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther. 2007, 114: 222-232.
Irwin M, McClintick J, Costlow C, Fortner M, White J, Gillin JC: Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J. 1996, 10: 643-653.
Simpson N, Dinges DF: Sleep and inflammation. Nutr Rev. 2007, 65: S244-252.
Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, Szuba MP, Van Dongen HP, Dinges DF: Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol. 2001, 107: 165-170.
Haack M, Sanchez E, Mullington JM: Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep. 2007, 30: 1145-1152.
Strike PC, Steptoe A: Systematic review of mental stress-induced myocardial ischaemia. Eur Heart J. 2003, 24: 690-703.
Wolk R, Somers VK: Sleep and the metabolic syndrome. Exp Physiol. 2007, 92: 67-78.
Vgontzas AN, Zoumakis M, Bixler EO, Lin HM, Prolo P, Vela-Bueno A, Kales A, Chrousos GP: Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab. 2003, 88: 2087-2095.
Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E: Correlates of serum C-reactive protein (CRP)–no association with sleep duration or sleep disordered breathing. Sleep. 2007, 30: 991-996.
Patel SR, Zhu X, Storfer-Isser A, Mehra R, Jenny NS, Tracy R, Redline S: Sleep duration and biomarkers of inflammation. Sleep. 2009, 32: 200-204.
Speigelhalder K, Scholtes C, Riemann D: The association between insomnia and cardiovascular disease. Nat Sci Sleep. 2010, 2: 71-78.
Novati A, Roman V, Cetin T, Hagewoud R, den Boer JA, Luiten PG, Meerlo P: Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats. Sleep. 2008, 31: 1579-1585.
Meerlo P, Koehl M, van der Borght K, Turek FW: Sleep restriction alters the hypothalamic-pituitary-adrenal response to stress. J Neuroendocrinol. 2002, 14: 397-402.
Krishnan V, Nestler EJ: The molecular neurobiology of depression. Nature. 2008, 455: 894-902.
Dunn AJ, Swiergiel AH, de Beaurepaire R: Cytokines as mediators of depression: what can we learn from animal studies?. Neurosci Biobehav Rev. 2005, 29: 891-909.
Chourbaji S, Urani A, Inta I, Sanchis-Segura C, Brandwein C, Zink M, Schwaninger M, Gass P: IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol Dis. 2006, 23: 587-594.
Lucassen PJ, Meerlo P, Naylor AS, van Dam AM, Dayer AG, Fuchs E, Oomen CA, Czeh B: Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: implications for depression and antidepressant action. Eur Neuropsychopharmacol. 2010, 20: 1-17.
Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K: Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci. 1995, 762: 474-476.
Pasco JA, Henry MJ, Nicholson GC, Sanders KM, Kotowicz MA: Vitamin D status of women in the Geelong osteoporosis study: association with diet and casual exposure to sunlight. Med J Aust. 2001, 175: 401-405.
Nowson CA, McGrath JJ, Ebeling PR, Haikerwal A, Daly RM, Sanders KM, Seibel MJ, Mason RS: Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust. 2012, 196: 686-687.
Eyles D, Burne T, McGrath J: Vitamin D in fetal brain development. Semin Cell Dev Biol. 2011, 22: 629-636.
Lansdowne AT, Provost SC: Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl). 1998, 135: 319-323.
Sanders KM, Stuart AL, Williamson EJ, Jacka FN, Dodd S, Nicholson G, Berk M: Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry. 2011, 198: 357-364.
Battersby AJ, Kampmann B, Burl S: Vitamin D in early childhood and the effect on immunity to mycobacterium tuberculosis. Clin Dev Immunol. 2012, 2012: 430972.
Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E: Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine. 2012, 60: 870-874.
Grossmann RE, Zughaier SM, Liu S, Lyles RH, Tangpricha V: Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutr. 2012, 66: 1072-1074.
Faridar A, Eskandari G, Sahraian MA, Minagar A, Azimi A: Vitamin D and multiple sclerosis: a critical review and recommendations on treatment. Acta Neurol Belg. 2012, 112: 327-333.
Jain S, Manna P, Micinski D, Lieblong B, Kahlon G, Morehead L, Hoeldtke R, Bass PF, Levine SN: In African American type 2 diabetic patients, is vitamin D deficiency associated with lower blood levels of H2S and cAMP, and elevated oxidative stress?. Antioxid Redox Signal. 2013, 18: 1154-1158.
Hart PH: Vitamin D supplementation, moderate sun exposure, and control of immune diseases. Discov Med. 2012, 13: 397-404.
Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY: Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res. 1995, 29: 141-152.
Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpe S: Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 1997, 66: 1-11.
Rapaport MH: Immune parameters in euthymic bipolar patients and normal volunteers. J Affect Disord. 1994, 32: 149-156.
Modabbernia A, Taslimi S, Brietzke E, Ashrafi M: Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013, [Epub ahead of print.]
Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B: Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011, 70: 663-671.
Spivak B, Shohat B, Mester R, Avraham S, Gil-Ad I, Bleich A, Valevski A, Weizman A: Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol Psychiatry. 1997, 42: 345-348.
Maes M, Lin AH, Delmeire L, Van Gastel A, Kenis G, De Jongh R, Bosmans E: Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry. 1999, 45: 833-839.
Gill J, Luckenbaugh D, Charney D, Vythilingam M: Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression. Biol Psychiatry. 2010, 68: 999-1006.
Gola H, Engler H, Sommershof A, Adenauer H, Kolassa S, Schedlowski M, Groettrup M, Elbert T, Kolassa IT: Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry. 2013, 13: 40.
Anderson G, Maes M: Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression. Prog Neuropsychopharmacol Biol Psychiatry. 2013, 42: 5-19.
de Leon J, Diaz FJ: A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005, 76: 135-157.
Citrome L, Vreeland B: Schizophrenia, obesity, and antipsychotic medications: what can we do?. Postgrad Med. 2008, 120: 18-33.
Chen YH, Lee HC, Lin HC: Prevalence and risk of atopic disorders among schizophrenia patients: a nationwide population based study. Schizophr Res. 2009, 108: 191-196.
Bersani FS, Iannitelli A, Pacitti F, Bersani G: Sleep and biorythm disturbances in schizophrenia, mood and anxiety disorders: a review. Riv Psichiatr. 2012, 47: 365-375.
Arnaiz A, Zumarraga M, Diez-Altuna I, Uriarte JJ, Moro J, Perez-Ansorena MA: Oral health and the symptoms of schizophrenia. Psychiatry Res. 2010, 188: 24-28.
Eltas A, Kartalci S, Eltas S, Dundar S, Uslu M: An assessment of periodontal health in patients with schizophrenia and taking antipsychotic medication. Int J Dent Hyg. 2013, 11: 78-83.
Thorndike FP, Wernicke R, Pearlman MY, Haaga DA: Nicotine dependence, PTSD symptoms, and depression proneness among male and female smokers. Addict Behav. 2006, 31: 223-231.
Heppner PS, Lohr JB, Kash TP, Jin H, Wang H, Baker DG: Metabolic syndrome: relative risk associated with post-traumatic stress disorder (PTSD) severity and antipsychotic medication use. Psychosomatics. 2012, 53: 550-558.
Muhvic-Urek M, Uhac I, Vuksic-Mihaljevic Z, Leovic D, Blecic N, Kovac Z: Oral health status in war veterans with post-traumatic stress disorder. J Oral Rehabil. 2007, 34: 1-8.
Gupta MA: Review of somatic symptoms in post-traumatic stress disorder. Int Rev Psychiatry. 2013, 25: 86-99.
Stafford L, Berk M: The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression?. J Clin Psychiatry. 2011, 72: 1229-1235.
Pasco JA, Jacka FN, Williams LJ, Henry MJ, Nicholson GC, Kotowicz MA, Berk M: Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. Psychother Psychosom. 2010, 79: 323-325.